| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.74e-07 | 188 | 118 | 10 | GO:0005201 | |
| GeneOntologyMolecularFunction | calcium ion binding | STAB2 PCDHGB7 DLL1 SNED1 THBS3 FAT1 SCUBE1 FBN1 FBN2 DST NOTCH2NLB LRP1 LRP2 LTBP2 AGRN NOTCH2 | 8.61e-06 | 749 | 118 | 16 | GO:0005509 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | ZNF793 TCF15 ZNF48 ZNF154 ZNF175 GTF2IRD1 ZNF865 HESX1 ZNF16 BCL11B ZNF530 ZNF544 ZNF41 ZNF516 ZNF667 PRDM16 TET3 NOTCH2 ZNF572 ZNF646 | 5.26e-05 | 1271 | 118 | 20 | GO:0000987 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.07e-04 | 16 | 118 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF793 ZHX3 TCF15 ZNF48 ZNF154 ZNF175 GTF2IRD1 ZNF865 HESX1 ZNF16 BCL11B ZNF35 ZNF530 ZNF544 ZNF41 ZNF516 ZNF667 PRDM16 TET3 ZNF572 ZNF646 | 1.19e-04 | 1459 | 118 | 21 | GO:0000977 |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | ZNF793 TCF15 ZNF48 ZNF154 ZNF175 GTF2IRD1 ZNF865 HESX1 ZNF16 BCL11B ZNF530 ZNF544 ZNF41 ZNF516 ZNF667 PRDM16 TET3 ZNF572 ZNF646 | 1.23e-04 | 1244 | 118 | 19 | GO:0000978 |
| GeneOntologyMolecularFunction | ephrin receptor activity | 1.82e-04 | 19 | 118 | 3 | GO:0005003 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF793 ZHX3 TCF15 ZNF48 ZNF154 ZNF175 GTF2IRD1 HESX1 ZNF16 AHRR BCL11B ZNF35 ZNF530 ZNF544 ZNF41 ZNF516 PRDM16 NOTCH2 ZNF572 ZNF646 | 2.19e-04 | 1412 | 118 | 20 | GO:0000981 |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 2.48e-04 | 21 | 118 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | ATPase inhibitor activity | 5.11e-04 | 6 | 118 | 2 | GO:0042030 | |
| GeneOntologyMolecularFunction | Notch binding | 5.31e-04 | 27 | 118 | 3 | GO:0005112 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 5.31e-04 | 27 | 118 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 5.94e-04 | 65 | 118 | 4 | GO:0004714 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 9.21e-04 | 73 | 118 | 4 | GO:0050840 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.62e-03 | 85 | 118 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.62e-03 | 85 | 118 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 2.20e-03 | 12 | 118 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity | COL4A5 COL5A1 LAMA2 ADD2 THBS3 FBN1 FBN2 DST SNTG1 COL14A1 LTBP2 AGRN MUC6 | 2.34e-03 | 891 | 118 | 13 | GO:0005198 |
| GeneOntologyMolecularFunction | growth factor binding | 2.35e-03 | 156 | 118 | 5 | GO:0019838 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 2.54e-03 | 46 | 118 | 3 | GO:0030020 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 3.01e-03 | 14 | 118 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 3.01e-03 | 14 | 118 | 2 | GO:0015132 | |
| GeneOntologyBiologicalProcess | axon guidance | CHL1 SEMA3C MYCBP2 LAMA2 ABLIM1 BCL11B SEMA5B LRP1 LRP2 AGRN UNC5D EPHA10 NOTCH2 | 8.75e-09 | 285 | 117 | 13 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | CHL1 SEMA3C MYCBP2 LAMA2 ABLIM1 BCL11B SEMA5B LRP1 LRP2 AGRN UNC5D EPHA10 NOTCH2 | 9.13e-09 | 286 | 117 | 13 | GO:0097485 |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | EPHB4 COL5A1 SEMA3C TCF15 ABCA12 KAT6A LAMA2 DLL1 AHDC1 HESX1 GREB1L MET ABLIM1 THBS3 FAT1 LIMS1 BCL11B FBN2 EPHA2 PKD1 LRP2 USH2A NOTCH2 | 6.14e-07 | 1269 | 117 | 23 | GO:0009887 |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 1.76e-06 | 5 | 117 | 3 | GO:1905167 | |
| GeneOntologyBiologicalProcess | axonogenesis | CHL1 SEMA3C MYCBP2 LAMA2 ABLIM1 BCL11B DST SEMA5B LRP1 LRP2 AGRN UNC5D EPHA10 NOTCH2 | 4.02e-06 | 566 | 117 | 14 | GO:0007409 |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 6.12e-06 | 7 | 117 | 3 | GO:1904352 | |
| GeneOntologyBiologicalProcess | axon development | CHL1 SEMA3C MYCBP2 LAMA2 ABLIM1 BCL11B DST SEMA5B LRP1 LRP2 AGRN UNC5D EPHA10 NOTCH2 | 1.67e-05 | 642 | 117 | 14 | GO:0061564 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | CHL1 SEMA3C MYCBP2 LAMA2 MET ABLIM1 BCL11B DST SEMA5B LRP1 LRP2 AGRN UNC5D EPHA10 NOTCH2 | 2.18e-05 | 748 | 117 | 15 | GO:0048667 |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 3.77e-05 | 12 | 117 | 3 | GO:1905165 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | CHL1 SEMA3C MYCBP2 LAMA2 MET ABLIM1 BCL11B DST SEMA5B LRP1 LRP2 AGRN UNC5D EPHA10 NOTCH2 | 4.85e-05 | 802 | 117 | 15 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | CHL1 SEMA3C MYCBP2 LAMA2 MET ABLIM1 BCL11B DST SEMA5B LRP1 LRP2 AGRN UNC5D EPHA10 NOTCH2 | 6.15e-05 | 819 | 117 | 15 | GO:0120039 |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 6.19e-05 | 14 | 117 | 3 | GO:1904350 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | CHL1 SEMA3C MYCBP2 LAMA2 MET ABLIM1 BCL11B DST SEMA5B LRP1 LRP2 AGRN UNC5D EPHA10 NOTCH2 | 6.77e-05 | 826 | 117 | 15 | GO:0048858 |
| GeneOntologyBiologicalProcess | heart development | EPHB4 COL5A1 SEMA3C KAT6A DLL1 GREB1L MET SCUBE1 FBN1 PKD1 LRP1 LRP2 COL14A1 NOTCH2 | 9.94e-05 | 757 | 117 | 14 | GO:0007507 |
| GeneOntologyBiologicalProcess | sequestering of TGFbeta in extracellular matrix | 1.90e-04 | 4 | 117 | 2 | GO:0035583 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | COL5A1 SEMA3C TCF15 DLL1 HESX1 GREB1L MET FAT1 EPHA2 PKD1 LRP2 NOTCH2 | 2.09e-04 | 619 | 117 | 12 | GO:0002009 |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 3.15e-04 | 5 | 117 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | lysosomal protein catabolic process | 3.30e-04 | 24 | 117 | 3 | GO:1905146 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | COL5A1 SEMA3C TCF15 DLL1 AHDC1 HESX1 GREB1L MET FAT1 EPHA2 PKD1 LRP2 NOTCH2 | 3.34e-04 | 750 | 117 | 13 | GO:0048729 |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | EPHB4 COL4A5 ELAPOR2 KCP DLL1 HESX1 MET FBN1 FBN2 EPHA2 LRP1 LRP2 LTBP2 PRDM16 AGRN EPHA10 NOTCH2 | 3.75e-04 | 1186 | 117 | 17 | GO:0007167 |
| GeneOntologyBiologicalProcess | cell morphogenesis | CHL1 SEMA3C MYCBP2 LAMA2 MET ABLIM1 FAT1 BCL11B DST SEMA5B EPHA2 LRP1 LRP2 AGRN UNC5D EPHA10 NOTCH2 | 4.05e-04 | 1194 | 117 | 17 | GO:0000902 |
| GeneOntologyBiologicalProcess | positive regulation of oligodendrocyte progenitor proliferation | 4.71e-04 | 6 | 117 | 2 | GO:0070447 | |
| GeneOntologyBiologicalProcess | circulatory system development | EPHB4 COL5A1 SEMA3C GGNBP2 STAB2 KAT6A CLIC3 DLL1 ADAM12 GREB1L MET SCUBE1 FBN1 EPHA2 PKD1 LRP1 LRP2 COL14A1 NOTCH2 | 4.73e-04 | 1442 | 117 | 19 | GO:0072359 |
| GeneOntologyCellularComponent | extracellular matrix | COL4A5 COL5A1 SEMA3C ADAMTSL1 ZAN CLIC3 LAMA2 MUC5B TF SNED1 SSC5D THBS3 FBN1 FBN2 FCGBP DST COL14A1 LTBP2 USH2A AGRN MUC6 | 1.27e-10 | 656 | 119 | 21 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A5 COL5A1 SEMA3C ADAMTSL1 ZAN CLIC3 LAMA2 MUC5B TF SNED1 SSC5D THBS3 FBN1 FBN2 FCGBP DST COL14A1 LTBP2 USH2A AGRN MUC6 | 1.35e-10 | 658 | 119 | 21 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A5 COL5A1 SEMA3C ADAMTSL1 LAMA2 TF SSC5D THBS3 FBN1 FBN2 DST COL14A1 LTBP2 USH2A AGRN | 3.47e-07 | 530 | 119 | 15 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 4.88e-07 | 122 | 119 | 8 | GO:0005604 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 9.39e-05 | 80 | 119 | 5 | GO:0005905 | |
| GeneOntologyCellularComponent | cell surface | STAB2 TF MET SCUBE1 LY6G6D KCNH2 EPHA2 IL21R TLR4 PKD1 LRP1 LRP2 AGRN UNC5D IL17RB NOTCH2 | 5.63e-04 | 1111 | 119 | 16 | GO:0009986 |
| GeneOntologyCellularComponent | cell leading edge | 5.82e-04 | 500 | 119 | 10 | GO:0031252 | |
| HumanPheno | Myopia | COL4A5 COL5A1 ADAMTSL1 KAT6A GTF2IRD1 AHDC1 BCL11B FBN1 FBN2 EPHA2 LRP2 LTBP2 GNB3 USH2A NOTCH2 | 1.19e-06 | 447 | 42 | 15 | HP:0000545 |
| HumanPheno | Abnormal mitral valve physiology | 1.14e-05 | 180 | 42 | 9 | HP:0031481 | |
| HumanPheno | Mitral regurgitation | 4.32e-05 | 163 | 42 | 8 | HP:0001653 | |
| HumanPheno | Abnormal atrioventricular valve physiology | 4.75e-05 | 215 | 42 | 9 | HP:0031650 | |
| HumanPheno | Abnormality of refraction | COL4A5 COL5A1 ADAMTSL1 KAT6A GTF2IRD1 AHDC1 BCL11B FBN1 FBN2 EPHA2 LRP2 LTBP2 GNB3 USH2A PRDM16 NOTCH2 | 8.15e-05 | 709 | 42 | 16 | HP:0000539 |
| MousePheno | perinatal lethality, complete penetrance | TCF15 MYCBP2 ABCA12 KAT6A DLL1 AHDC1 HESX1 MET FAT1 SCUBE1 BCL11B ZNF516 PKD1 LRP1 LRP2 PRDM16 AGRN NOTCH2 | 2.08e-07 | 712 | 85 | 18 | MP:0011089 |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | GGNBP2 TCF15 MYCBP2 ABCA12 KAT6A DLL1 TF AHDC1 HESX1 MET FAT1 SCUBE1 BCL11B FBN1 DST ZNF516 PKD1 LRP1 LRP2 PRDM16 AGRN NOTCH2 | 4.70e-06 | 1269 | 85 | 22 | MP:0011111 |
| MousePheno | perinatal lethality | SEMA3C TCF15 MYCBP2 ABCA12 KAT6A LAMA2 DLL1 AHDC1 HESX1 MET FAT1 SCUBE1 BCL11B ZNF516 PKD1 LRP1 LRP2 PRDM16 AGRN NOTCH2 | 1.05e-05 | 1130 | 85 | 20 | MP:0002081 |
| MousePheno | premature bone ossification | 1.72e-05 | 26 | 85 | 4 | MP:0003416 | |
| MousePheno | abnormal muscle electrophysiology | 4.02e-05 | 32 | 85 | 4 | MP:0004145 | |
| MousePheno | abnormal skeletal muscle morphology | TCF15 MYCBP2 LAMA2 GTF2IRD1 DLL1 ADAM12 MET FBN1 FBN2 DST LRP1 AGRN | 5.48e-05 | 508 | 85 | 12 | MP:0000759 |
| MousePheno | micrognathia | 5.70e-05 | 68 | 85 | 5 | MP:0002639 | |
| MousePheno | abnormal aorta morphology | 6.60e-05 | 225 | 85 | 8 | MP:0000272 | |
| MousePheno | neonatal lethality | SEMA3C TCF15 MYCBP2 ABCA12 KAT6A HESX1 MET FAT1 SCUBE1 BCL11B ZNF516 PKD1 PRDM16 AGRN NOTCH2 | 8.39e-05 | 799 | 85 | 15 | MP:0002058 |
| MousePheno | neonatal lethality, complete penetrance | TCF15 MYCBP2 ABCA12 KAT6A MET FAT1 SCUBE1 BCL11B ZNF516 PKD1 PRDM16 AGRN | 8.83e-05 | 534 | 85 | 12 | MP:0011087 |
| MousePheno | abnormal muscle morphology | EPHB4 TCF15 MYCBP2 LAMA2 GTF2IRD1 DLL1 ADAM12 MET FBN1 FBN2 DST PKD1 LRP1 LRP2 SRL COL14A1 AGRN NOTCH2 | 9.51e-05 | 1106 | 85 | 18 | MP:0002108 |
| MousePheno | abnormal skeleton physiology | TCF15 LAMA2 GC AHDC1 THBS3 FBN1 FBN2 TLR4 PKD1 PAPPA COL14A1 PRDM16 NOTCH2 | 1.07e-04 | 632 | 85 | 13 | MP:0001533 |
| MousePheno | abnormal craniofacial morphology | CHL1 TCF15 ABCA12 KAT6A LAMA2 GTF2IRD1 AHDC1 HESX1 MET FAT1 SCUBE1 BCL11B FBN1 FBN2 DST KCNH2 PKD1 LRP1 LRP2 PRDM16 | 1.65e-04 | 1372 | 85 | 20 | MP:0000428 |
| MousePheno | craniofacial phenotype | CHL1 TCF15 ABCA12 KAT6A LAMA2 GTF2IRD1 AHDC1 HESX1 MET FAT1 SCUBE1 BCL11B FBN1 FBN2 DST KCNH2 PKD1 LRP1 LRP2 PRDM16 | 1.65e-04 | 1372 | 85 | 20 | MP:0005382 |
| MousePheno | paresis | 2.97e-04 | 53 | 85 | 4 | MP:0000754 | |
| Domain | EGF-like_CS | EPHB4 STAB2 ZAN LAMA2 DLL1 ADAM12 SNED1 THBS3 FAT1 SCUBE1 FBN1 FBN2 EPHA2 LRP1 LRP2 LTBP2 AGRN EPHA10 NOTCH2 | 1.85e-15 | 261 | 114 | 19 | IPR013032 |
| Domain | EGF_2 | EPHB4 STAB2 ZAN LAMA2 DLL1 ADAM12 SNED1 THBS3 FAT1 SCUBE1 FBN1 FBN2 EPHA2 LRP1 LRP2 LTBP2 AGRN EPHA10 NOTCH2 | 2.45e-15 | 265 | 114 | 19 | PS01186 |
| Domain | EGF-like_dom | STAB2 ZAN LAMA2 DLL1 ADAM12 SNED1 THBS3 FAT1 SCUBE1 FBN1 FBN2 FCGBP LRP1 LRP2 LTBP2 AGRN NOTCH2 | 1.81e-13 | 249 | 114 | 17 | IPR000742 |
| Domain | EGF_1 | STAB2 ZAN LAMA2 DLL1 ADAM12 SNED1 THBS3 FAT1 SCUBE1 FBN1 FBN2 LRP1 LRP2 LTBP2 USH2A AGRN NOTCH2 | 2.67e-13 | 255 | 114 | 17 | PS00022 |
| Domain | EGF_CA | STAB2 DLL1 SNED1 THBS3 FAT1 SCUBE1 FBN1 FBN2 LRP1 LRP2 LTBP2 AGRN NOTCH2 | 5.10e-13 | 122 | 114 | 13 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | STAB2 DLL1 SNED1 THBS3 FAT1 SCUBE1 FBN1 FBN2 LRP1 LRP2 LTBP2 AGRN NOTCH2 | 6.31e-13 | 124 | 114 | 13 | IPR001881 |
| Domain | Growth_fac_rcpt_ | EPHB4 ELAPOR2 STAB2 DLL1 THBS3 FAT1 SCUBE1 FBN1 FBN2 EPHA2 LRP1 LRP2 LTBP2 NOTCH2 | 6.79e-13 | 156 | 114 | 14 | IPR009030 |
| Domain | EGF | STAB2 ZAN LAMA2 DLL1 SNED1 THBS3 FAT1 SCUBE1 FBN1 FBN2 FCGBP LRP1 LRP2 LTBP2 AGRN NOTCH2 | 1.02e-12 | 235 | 114 | 16 | SM00181 |
| Domain | EGF_3 | STAB2 ZAN DLL1 ADAM12 SNED1 THBS3 FAT1 SCUBE1 FBN1 FBN2 LRP1 LRP2 LTBP2 AGRN NOTCH2 | 1.39e-11 | 235 | 114 | 15 | PS50026 |
| Domain | EGF_Ca-bd_CS | DLL1 SNED1 THBS3 FAT1 SCUBE1 FBN1 FBN2 LRP1 LRP2 LTBP2 NOTCH2 | 1.72e-11 | 97 | 114 | 11 | IPR018097 |
| Domain | EGF_CA | DLL1 SNED1 THBS3 FAT1 SCUBE1 FBN1 FBN2 LRP1 LRP2 LTBP2 NOTCH2 | 2.15e-11 | 99 | 114 | 11 | PS01187 |
| Domain | TIL_dom | 1.31e-10 | 14 | 114 | 6 | IPR002919 | |
| Domain | ASX_HYDROXYL | 5.25e-10 | 100 | 114 | 10 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 9.38e-10 | 106 | 114 | 10 | IPR000152 | |
| Domain | EGF_CA | 2.65e-09 | 86 | 114 | 9 | PF07645 | |
| Domain | EGF | 5.12e-09 | 126 | 114 | 10 | PF00008 | |
| Domain | Unchr_dom_Cys-rich | 9.60e-09 | 13 | 114 | 5 | IPR014853 | |
| Domain | C8 | 9.60e-09 | 13 | 114 | 5 | SM00832 | |
| Domain | VWF_type-D | 3.21e-08 | 16 | 114 | 5 | IPR001846 | |
| Domain | VWFD | 3.21e-08 | 16 | 114 | 5 | PS51233 | |
| Domain | VWD | 3.21e-08 | 16 | 114 | 5 | SM00216 | |
| Domain | VWD | 3.21e-08 | 16 | 114 | 5 | PF00094 | |
| Domain | Laminin_G | 6.09e-08 | 58 | 114 | 7 | IPR001791 | |
| Domain | VWC_out | 8.42e-08 | 19 | 114 | 5 | SM00215 | |
| Domain | Ephrin_rec_like | 3.74e-07 | 25 | 114 | 5 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 3.74e-07 | 25 | 114 | 5 | IPR011641 | |
| Domain | LDLRA_1 | 4.51e-07 | 48 | 114 | 6 | PS01209 | |
| Domain | cEGF | 4.61e-07 | 26 | 114 | 5 | PF12662 | |
| Domain | cEGF | 4.61e-07 | 26 | 114 | 5 | IPR026823 | |
| Domain | LDLRA_2 | 5.11e-07 | 49 | 114 | 6 | PS50068 | |
| Domain | C8 | 6.28e-07 | 12 | 114 | 4 | PF08742 | |
| Domain | TIL | 6.28e-07 | 12 | 114 | 4 | PF01826 | |
| Domain | - | 1.86e-06 | 95 | 114 | 7 | 2.60.120.200 | |
| Domain | LAM_G_DOMAIN | 3.32e-06 | 38 | 114 | 5 | PS50025 | |
| Domain | - | ZNF793 ZNF48 ZNF154 ZNF175 ZNF865 ZNF16 BCL11B ZNF35 ZNF530 ZNF544 ZNF41 ZNF516 ZNF667 PRDM16 ZNF572 ZNF646 | 3.66e-06 | 679 | 114 | 16 | 3.30.160.60 |
| Domain | LDLR_class-A_CS | 4.30e-06 | 40 | 114 | 5 | IPR023415 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF793 ZHX3 ZNF48 ZNF154 ZNF175 ZNF865 ZNF16 BCL11B ZNF35 ZNF530 ZNF544 ZNF41 ZNF516 ZNF667 PRDM16 ZNF572 ZNF646 | 4.60e-06 | 775 | 114 | 17 | PS50157 |
| Domain | zf-C2H2 | ZNF793 ZNF48 ZNF154 ZNF175 ZNF865 ZNF16 BCL11B ZNF35 ZNF530 ZNF544 ZNF41 ZNF516 ZNF667 PRDM16 ZNF572 ZNF646 | 4.74e-06 | 693 | 114 | 16 | PF00096 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF793 ZHX3 ZNF48 ZNF154 ZNF175 ZNF865 ZNF16 BCL11B ZNF35 ZNF530 ZNF544 ZNF41 ZNF516 ZNF667 PRDM16 ZNF572 ZNF646 | 4.76e-06 | 777 | 114 | 17 | PS00028 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF793 ZNF48 ZNF154 ZNF175 ZNF865 ZNF16 BCL11B ZNF35 ZNF530 ZNF544 ZNF41 ZNF516 ZNF667 PRDM16 ZNF572 ZNF646 | 4.83e-06 | 694 | 114 | 16 | IPR013087 |
| Domain | VWF_dom | 5.51e-06 | 42 | 114 | 5 | IPR001007 | |
| Domain | Znf_C2H2-like | ZNF793 ZHX3 ZNF48 ZNF154 ZNF175 ZNF865 ZNF16 BCL11B ZNF35 ZNF530 ZNF544 ZNF41 ZNF516 ZNF667 PRDM16 ZNF572 ZNF646 | 6.55e-06 | 796 | 114 | 17 | IPR015880 |
| Domain | LamG | 6.97e-06 | 44 | 114 | 5 | SM00282 | |
| Domain | Znf_C2H2 | ZNF793 ZHX3 ZNF48 ZNF154 ZNF175 ZNF865 ZNF16 BCL11B ZNF35 ZNF530 ZNF544 ZNF41 ZNF516 ZNF667 PRDM16 ZNF572 ZNF646 | 7.59e-06 | 805 | 114 | 17 | IPR007087 |
| Domain | TB | 7.61e-06 | 7 | 114 | 3 | PF00683 | |
| Domain | ConA-like_dom | 7.94e-06 | 219 | 114 | 9 | IPR013320 | |
| Domain | ZnF_C2H2 | ZNF793 ZHX3 ZNF48 ZNF154 ZNF175 ZNF865 ZNF16 BCL11B ZNF35 ZNF530 ZNF544 ZNF41 ZNF516 ZNF667 PRDM16 ZNF572 ZNF646 | 7.97e-06 | 808 | 114 | 17 | SM00355 |
| Domain | - | 8.71e-06 | 46 | 114 | 5 | 4.10.400.10 | |
| Domain | LDrepeatLR_classA_rpt | 1.19e-05 | 49 | 114 | 5 | IPR002172 | |
| Domain | LDLa | 1.19e-05 | 49 | 114 | 5 | SM00192 | |
| Domain | - | 1.21e-05 | 8 | 114 | 3 | 3.90.290.10 | |
| Domain | FN3 | 1.79e-05 | 185 | 114 | 8 | SM00060 | |
| Domain | TB_dom | 1.81e-05 | 9 | 114 | 3 | IPR017878 | |
| Domain | TB | 1.81e-05 | 9 | 114 | 3 | PS51364 | |
| Domain | hEGF | 2.41e-05 | 28 | 114 | 4 | PF12661 | |
| Domain | FN3 | 3.03e-05 | 199 | 114 | 8 | PS50853 | |
| Domain | EGF_LAM_2 | 3.19e-05 | 30 | 114 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 3.19e-05 | 30 | 114 | 4 | PS01248 | |
| Domain | Fol_N | 3.53e-05 | 11 | 114 | 3 | IPR003645 | |
| Domain | FOLN | 3.53e-05 | 11 | 114 | 3 | SM00274 | |
| Domain | FN3_dom | 4.29e-05 | 209 | 114 | 8 | IPR003961 | |
| Domain | - | CHL1 EPHB4 SEMA3C ADAMTSL1 MYCBP2 SNED1 MET EPHA2 IL21R COL14A1 TGM7 USH2A UNC5D EPHA10 | 5.20e-05 | 663 | 114 | 14 | 2.60.40.10 |
| Domain | EGF_Lam | 5.96e-05 | 35 | 114 | 4 | SM00180 | |
| Domain | fn3 | 6.13e-05 | 162 | 114 | 7 | PF00041 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 7.68e-05 | 14 | 114 | 3 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 7.68e-05 | 14 | 114 | 3 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 7.68e-05 | 14 | 114 | 3 | IPR001426 | |
| Domain | EphA2_TM | 7.68e-05 | 14 | 114 | 3 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 7.68e-05 | 14 | 114 | 3 | IPR001090 | |
| Domain | Eph_TM | 7.68e-05 | 14 | 114 | 3 | IPR027936 | |
| Domain | EPH_lbd | 7.68e-05 | 14 | 114 | 3 | SM00615 | |
| Domain | Ephrin_lbd | 7.68e-05 | 14 | 114 | 3 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 7.68e-05 | 14 | 114 | 3 | IPR016257 | |
| Domain | EPH_LBD | 7.68e-05 | 14 | 114 | 3 | PS51550 | |
| Domain | VWC | 8.28e-05 | 38 | 114 | 4 | SM00214 | |
| Domain | Laminin_EGF | 8.28e-05 | 38 | 114 | 4 | IPR002049 | |
| Domain | - | 8.37e-05 | 73 | 114 | 5 | 2.60.120.260 | |
| Domain | Ig-like_fold | CHL1 EPHB4 SEMA3C ADAMTSL1 MYCBP2 SNED1 MET EPHA2 IL21R COL14A1 TGM7 USH2A UNC5D EPHA10 | 1.02e-04 | 706 | 114 | 14 | IPR013783 |
| Domain | Laminin_G_2 | 1.02e-04 | 40 | 114 | 4 | PF02210 | |
| Domain | TILa_dom | 1.10e-04 | 3 | 114 | 2 | IPR025615 | |
| Domain | TILa | 1.10e-04 | 3 | 114 | 2 | PF12714 | |
| Domain | FRG2 | 1.10e-04 | 3 | 114 | 2 | PF15315 | |
| Domain | FRG2 | 1.10e-04 | 3 | 114 | 2 | IPR026245 | |
| Domain | FBN | 1.10e-04 | 3 | 114 | 2 | IPR011398 | |
| Domain | zf-C2H2_6 | ZNF48 ZNF154 ZNF865 ZNF16 ZNF530 ZNF667 PRDM16 ZNF572 ZNF646 | 1.32e-04 | 314 | 114 | 9 | PF13912 |
| Domain | Ldl_recept_a | 1.62e-04 | 45 | 114 | 4 | PF00057 | |
| Domain | LamGL | 2.20e-04 | 4 | 114 | 2 | SM00560 | |
| Domain | LamG-like | 2.20e-04 | 4 | 114 | 2 | IPR006558 | |
| Domain | Galactose-bd-like | 2.76e-04 | 94 | 114 | 5 | IPR008979 | |
| Domain | TSPN | 3.59e-04 | 23 | 114 | 3 | SM00210 | |
| Domain | NUT | 3.65e-04 | 5 | 114 | 2 | IPR024310 | |
| Domain | WSC | 3.65e-04 | 5 | 114 | 2 | SM00321 | |
| Domain | NUT_N | 3.65e-04 | 5 | 114 | 2 | IPR024309 | |
| Domain | NUT | 3.65e-04 | 5 | 114 | 2 | PF12881 | |
| Domain | WSC | 3.65e-04 | 5 | 114 | 2 | PS51212 | |
| Domain | WSC_carb-bd | 3.65e-04 | 5 | 114 | 2 | IPR002889 | |
| Domain | WSC | 3.65e-04 | 5 | 114 | 2 | PF01822 | |
| Domain | EGF_extracell | 4.93e-04 | 60 | 114 | 4 | IPR013111 | |
| Domain | EGF_2 | 4.93e-04 | 60 | 114 | 4 | PF07974 | |
| Domain | Notch_dom | 7.60e-04 | 7 | 114 | 2 | IPR000800 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A5 COL5A1 LAMA2 ADAM12 SCUBE1 FBN1 FBN2 DST COL14A1 LTBP2 AGRN | 1.58e-06 | 300 | 84 | 11 | M610 |
| Pathway | KEGG_AXON_GUIDANCE | 1.15e-05 | 129 | 84 | 7 | M5539 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.23e-05 | 258 | 84 | 9 | MM14572 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 5.17e-05 | 68 | 84 | 5 | M27303 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 6.81e-05 | 72 | 84 | 5 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 7.28e-05 | 73 | 84 | 5 | MM15906 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 8.60e-05 | 381 | 84 | 10 | M48063 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.58e-04 | 46 | 84 | 4 | M198 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.86e-04 | 140 | 84 | 6 | M587 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.08e-04 | 143 | 84 | 6 | M27275 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 4.16e-04 | 59 | 84 | 4 | M27218 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 4.27e-04 | 25 | 84 | 3 | M39713 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 4.73e-04 | 61 | 84 | 4 | M27103 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.88e-04 | 114 | 84 | 5 | MM14571 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | CHL1 EPHB4 COL4A5 COL5A1 LAMA2 MET ABLIM1 EPHA2 AGRN UNC5D EPHA10 | 5.88e-04 | 575 | 84 | 11 | M29853 |
| Pathway | PID_INTEGRIN1_PATHWAY | 6.38e-04 | 66 | 84 | 4 | M18 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 7.38e-04 | 30 | 84 | 3 | M27772 | |
| Pathway | WP_AXON_GUIDANCE | 8.87e-04 | 72 | 84 | 4 | M48335 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 8.94e-04 | 32 | 84 | 3 | MM14854 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 1.07e-03 | 34 | 84 | 3 | MM15025 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.09e-03 | 76 | 84 | 4 | M27219 | |
| Pubmed | 7.79e-09 | 167 | 121 | 9 | 22159717 | ||
| Pubmed | 1.17e-08 | 175 | 121 | 9 | 28071719 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | COL5A1 SEMA3C LAMA2 ADAM12 SSC5D FBN1 PAPPA COL14A1 LTBP2 AGRN | 1.79e-08 | 248 | 121 | 10 | 24006456 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EPHB4 COL4A5 ZNF48 MYCBP2 KAT6A GTF2IRD1 DLL1 ZNF865 AHDC1 FAT1 DST KCNH2 ZNF516 PKD1 LRP3 PRDM16 AGRN NOTCH2 | 5.54e-08 | 1105 | 121 | 18 | 35748872 |
| Pubmed | 1.86e-07 | 71 | 121 | 6 | 33541421 | ||
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 19047013 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 4.96e-07 | 135 | 121 | 7 | 28675934 | |
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 5.86e-07 | 86 | 121 | 6 | 28327460 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EPHB4 COL4A5 COL5A1 CACNA2D1 SEMA3C MYCBP2 ADAM12 MET THBS3 FAT1 FBN1 FBN2 EPHA2 LRP1 LTBP2 AGRN NOTCH2 | 9.47e-07 | 1201 | 121 | 17 | 35696571 |
| Pubmed | 3.09e-06 | 29 | 121 | 4 | 22613833 | ||
| Pubmed | 3.56e-06 | 30 | 121 | 4 | 20301299 | ||
| Pubmed | COL5A1 SEMA3C ZNF154 MYCBP2 MARCHF2 LAMA2 AHDC1 ADD2 TASOR2 GREB1L FAT1 FBN2 PKD1 COL14A1 AGRN UNC5D | 5.10e-06 | 1215 | 121 | 16 | 15146197 | |
| Pubmed | 6.64e-06 | 11 | 121 | 3 | 9242490 | ||
| Pubmed | The bHLH regulator pMesogenin1 is required for maturation and segmentation of paraxial mesoderm. | 8.83e-06 | 12 | 121 | 3 | 11124811 | |
| Pubmed | 8.83e-06 | 12 | 121 | 3 | 17572911 | ||
| Pubmed | 1.15e-05 | 13 | 121 | 3 | 11262239 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 12399449 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 21851253 | ||
| Pubmed | New Evidence Supporting the Role of FBN1 in the Development of Adolescent Idiopathic Scoliosis. | 1.20e-05 | 2 | 121 | 2 | 30044367 | |
| Pubmed | Material and mechanical properties of bones deficient for fibrillin-1 or fibrillin-2 microfibrils. | 1.20e-05 | 2 | 121 | 2 | 21440062 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 15131124 | ||
| Pubmed | Microfibril structure masks fibrillin-2 in postnatal tissues. | 1.20e-05 | 2 | 121 | 2 | 20404337 | |
| Pubmed | Fibrillln mutations in Marfan syndrome and related phenotypes. | 1.20e-05 | 2 | 121 | 2 | 8791520 | |
| Pubmed | Fibrillin genes map to regions of conserved mouse/human synteny on mouse chromosomes 2 and 18. | 1.20e-05 | 2 | 121 | 2 | 8307578 | |
| Pubmed | Developmental expression of fibrillin genes suggests heterogeneity of extracellular microfibrils. | 1.20e-05 | 2 | 121 | 2 | 7744963 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 26408953 | ||
| Pubmed | Evaluation of EphA2 and EphB4 as Targets for Image-Guided Colorectal Cancer Surgery. | 1.20e-05 | 2 | 121 | 2 | 28165374 | |
| Pubmed | Arg-Gly-Asp-containing domains of fibrillins-1 and -2 distinctly regulate lung fibroblast migration. | 1.20e-05 | 2 | 121 | 2 | 18006876 | |
| Pubmed | Rare variants in FBN1 and FBN2 are associated with severe adolescent idiopathic scoliosis. | 1.20e-05 | 2 | 121 | 2 | 24833718 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 16103356 | ||
| Pubmed | Exome sequencing identified new mutations in a Marfan syndrome family. | 1.20e-05 | 2 | 121 | 2 | 24484584 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 24265020 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 20529844 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 23133647 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 24867584 | ||
| Pubmed | Linkage of Marfan syndrome and a phenotypically related disorder to two different fibrillin genes. | 1.20e-05 | 2 | 121 | 2 | 1852206 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 12429739 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 14660750 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 34445520 | ||
| Pubmed | Fibrillin-1 and fibrillin-2 in human embryonic and early fetal development. | 1.20e-05 | 2 | 121 | 2 | 12524050 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 8120105 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 35419902 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 33529444 | ||
| Pubmed | Fibrillin assembly: dimer formation mediated by amino-terminal sequences. | 1.20e-05 | 2 | 121 | 2 | 10504303 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 28724630 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 29856234 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 10087992 | ||
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 28827396 | ||
| Pubmed | Immunohistochemical expression of fibrillin-1 and fibrillin-2 during tooth development. | 1.20e-05 | 2 | 121 | 2 | 25524144 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 26697810 | ||
| Pubmed | Fibrillins 1 and 2 perform partially overlapping functions during aortic development. | 1.20e-05 | 2 | 121 | 2 | 16407178 | |
| Pubmed | Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis. | 1.20e-05 | 2 | 121 | 2 | 31990681 | |
| Pubmed | 1.20e-05 | 2 | 121 | 2 | 10359653 | ||
| Pubmed | 1.28e-05 | 146 | 121 | 6 | 27068509 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 2.34e-05 | 97 | 121 | 5 | 27559042 | |
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 2.66e-05 | 247 | 121 | 7 | 39238192 | |
| Pubmed | 2.70e-05 | 17 | 121 | 3 | 15155583 | ||
| Pubmed | Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. | 2.70e-05 | 17 | 121 | 3 | 12217323 | |
| Pubmed | 2.84e-05 | 50 | 121 | 4 | 23658023 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 2.85e-05 | 101 | 121 | 5 | 20551380 | |
| Pubmed | 3.23e-05 | 18 | 121 | 3 | 18093989 | ||
| Pubmed | 3.43e-05 | 105 | 121 | 5 | 30280653 | ||
| Pubmed | ABCA12 KAT6A TF FAT1 BCL11B FBN2 IL21R LRP1 LRP2 PPIH PRDM16 UNC5D NOTCH2 ZNF646 | 3.53e-05 | 1116 | 121 | 14 | 31753913 | |
| Pubmed | 3.58e-05 | 53 | 121 | 4 | 24982181 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 10825173 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 19003798 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 14676276 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 24071006 | ||
| Pubmed | Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3). | 3.59e-05 | 3 | 121 | 2 | 11717447 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 25578880 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 30201140 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 22015022 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 8152808 | ||
| Pubmed | Hepatocyte growth factor, a determinant of airspace homeostasis in the murine lung. | 3.59e-05 | 3 | 121 | 2 | 23459311 | |
| Pubmed | Genetics of migraine in the age of genome-wide association studies. | 3.59e-05 | 3 | 121 | 2 | 22072275 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 24567328 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 11823422 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 17107962 | ||
| Pubmed | The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidney. | 3.59e-05 | 3 | 121 | 2 | 26542179 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 20855508 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 22456610 | ||
| Pubmed | Notch signaling confers antigen-presenting cell functions on mast cells. | 3.59e-05 | 3 | 121 | 2 | 19130928 | |
| Pubmed | Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin. | 3.59e-05 | 3 | 121 | 2 | 11829491 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 35454329 | ||
| Pubmed | Stabilin receptors clear LPS and control systemic inflammation. | 3.59e-05 | 3 | 121 | 2 | 34816100 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 21408136 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 35041723 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 23755898 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 17293099 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 18003638 | ||
| Pubmed | Notch ligand Delta-like 1 is essential for postnatal arteriogenesis. | 3.59e-05 | 3 | 121 | 2 | 17234965 | |
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 21666692 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 15976178 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 15520407 | ||
| Pubmed | 3.59e-05 | 3 | 121 | 2 | 7959795 | ||
| Pubmed | 3.82e-05 | 19 | 121 | 3 | 33597191 | ||
| Pubmed | Bcl11a (Ctip1) Controls Migration of Cortical Projection Neurons through Regulation of Sema3c. | 6.03e-05 | 22 | 121 | 3 | 26182416 | |
| Pubmed | 6.03e-05 | 22 | 121 | 3 | 27527664 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | COL4A5 COL5A1 ZNF793 MYCBP2 KAT6A FBXL17 GTF2IRD1 AHDC1 TASOR2 ABLIM1 ZNF544 LRP1 TMPRSS2 SNX9 TET3 NOTCH2 | 6.07e-05 | 1489 | 121 | 16 | 28611215 |
| Pubmed | 7.17e-05 | 4 | 121 | 2 | 23929584 | ||
| Interaction | IGFL3 interactions | 2.36e-07 | 75 | 115 | 7 | int:IGFL3 | |
| Interaction | ZFP41 interactions | 8.67e-07 | 57 | 115 | 6 | int:ZFP41 | |
| Interaction | CUBN interactions | 1.31e-06 | 15 | 115 | 4 | int:CUBN | |
| Interaction | FBXO2 interactions | EPHB4 CACNA2D1 SEMA3C SNED1 MET FBN1 FBN2 LRP2 COL14A1 SNX9 AGRN NOTCH2 | 4.10e-06 | 411 | 115 | 12 | int:FBXO2 |
| Interaction | DCN interactions | 4.49e-06 | 43 | 115 | 5 | int:DCN | |
| Interaction | NTN5 interactions | 9.79e-06 | 24 | 115 | 4 | int:NTN5 | |
| Interaction | FBN2 interactions | 3.49e-05 | 65 | 115 | 5 | int:FBN2 | |
| Interaction | LLCFC1 interactions | 6.83e-05 | 121 | 115 | 6 | int:LLCFC1 | |
| Interaction | ZDHHC15 interactions | 8.18e-05 | 125 | 115 | 6 | int:ZDHHC15 | |
| Interaction | IGFBP4 interactions | 8.66e-05 | 41 | 115 | 4 | int:IGFBP4 | |
| Interaction | LRRIQ1 interactions | 1.05e-04 | 43 | 115 | 4 | int:LRRIQ1 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF793 ZHX3 ZNF48 ZNF154 ZNF175 ZNF865 ZNF16 BCL11B ZNF35 ZNF530 ZNF544 ZNF41 ZNF516 ZNF667 PRDM16 ZNF572 ZNF646 | 2.21e-08 | 718 | 83 | 17 | 28 |
| GeneFamily | Fibronectin type III domain containing | 8.80e-06 | 160 | 83 | 7 | 555 | |
| GeneFamily | Low density lipoprotein receptors | 2.58e-05 | 13 | 83 | 3 | 634 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 3.27e-05 | 14 | 83 | 3 | 1095 | |
| GeneFamily | Collagens | 1.23e-03 | 46 | 83 | 3 | 490 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 3.75e-03 | 20 | 83 | 2 | 736 | |
| GeneFamily | CD molecules|Mucins | 4.13e-03 | 21 | 83 | 2 | 648 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 5.83e-03 | 25 | 83 | 2 | 504 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.45e-03 | 161 | 83 | 4 | 593 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 6.78e-03 | 27 | 83 | 2 | 1253 | |
| GeneFamily | Sterile alpha motif domain containing | 7.73e-03 | 88 | 83 | 3 | 760 | |
| Coexpression | NABA_CORE_MATRISOME | COL4A5 COL5A1 LAMA2 KCP SNED1 THBS3 FBN1 FBN2 COL14A1 LTBP2 USH2A AGRN | 4.91e-09 | 275 | 119 | 12 | M5884 |
| Coexpression | NABA_MATRISOME | COL4A5 COL5A1 SEMA3C ADAMTSL1 LAMA2 KCP MUC5B ADAM12 SNED1 THBS3 SCUBE1 FBN1 FBN2 SEMA5B PAPPA COL14A1 TGM7 LTBP2 USH2A AGRN MUC6 | 6.91e-09 | 1026 | 119 | 21 | M5889 |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 1.33e-08 | 137 | 119 | 9 | M40313 | |
| Coexpression | NABA_MATRISOME | COL4A5 COL5A1 SEMA3C ADAMTSL1 LAMA2 KCP MUC5B ADAM12 SNED1 THBS3 SCUBE1 FBN1 FBN2 SEMA5B PAPPA COL14A1 TGM7 LTBP2 AGRN MUC6 | 2.77e-08 | 1008 | 119 | 20 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | COL4A5 COL5A1 LAMA2 KCP SNED1 THBS3 FBN1 FBN2 COL14A1 LTBP2 AGRN | 4.46e-08 | 270 | 119 | 11 | MM17057 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.90e-07 | 196 | 119 | 9 | M3008 | |
| Coexpression | BOQUEST_STEM_CELL_UP | CHL1 COL5A1 SEMA3C LAMA2 FAT1 FBN1 LRP1 COL14A1 LTBP2 NOTCH2 | 3.31e-07 | 261 | 119 | 10 | M1834 |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 5.16e-07 | 35 | 119 | 5 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 5.97e-07 | 36 | 119 | 5 | MM1212 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.70e-06 | 191 | 119 | 8 | MM17059 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 3.80e-06 | 200 | 119 | 8 | M5930 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 8.79e-06 | 29 | 119 | 4 | MM17055 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_AIRWAY_SMC_CELL | 1.45e-05 | 115 | 119 | 6 | M45671 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_2_CELL | 2.57e-05 | 189 | 119 | 7 | M45678 | |
| Coexpression | GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_UP | 2.94e-05 | 193 | 119 | 7 | M6130 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 3.25e-05 | 350 | 119 | 9 | M1949 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 3.25e-05 | 40 | 119 | 4 | M5887 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP | 3.58e-05 | 199 | 119 | 7 | M9320 | |
| Coexpression | GSE17721_LPS_VS_POLYIC_2H_BMDC_UP | 3.69e-05 | 200 | 119 | 7 | M3801 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 3.79e-05 | 357 | 119 | 9 | MM828 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 4.59e-05 | 141 | 119 | 6 | M10381 | |
| Coexpression | MEL18_DN.V1_UP | 4.59e-05 | 141 | 119 | 6 | M2784 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 5.57e-05 | 146 | 119 | 6 | MM973 | |
| Coexpression | SMID_BREAST_CANCER_NORMAL_LIKE_UP | 7.55e-05 | 485 | 119 | 10 | M8513 | |
| Coexpression | HEVNER_TELENCEPHALON_MENINGEAL_CELLS | 7.92e-05 | 50 | 119 | 4 | MM403 | |
| Coexpression | FARMER_BREAST_CANCER_CLUSTER_4 | 8.38e-05 | 19 | 119 | 3 | M15125 | |
| Coexpression | SENESE_HDAC3_TARGETS_UP | 8.93e-05 | 495 | 119 | 10 | M8451 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | CHL1 COL4A5 COL5A1 FAM13C SNED1 FBN1 LRP1 PAPPA COL14A1 LTBP2 | 1.05e-04 | 505 | 119 | 10 | M39167 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL | 1.14e-04 | 104 | 119 | 5 | M45682 | |
| Coexpression | DESCARTES_FETAL_SPLEEN_VASCULAR_ENDOTHELIAL_CELLS | 1.62e-04 | 60 | 119 | 4 | M40290 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K27ME3 | 1.83e-04 | 345 | 119 | 8 | M2009 | |
| Coexpression | MIKKELSEN_NPC_HCP_WITH_H3K27ME3 | 1.91e-04 | 347 | 119 | 8 | MM860 | |
| Coexpression | OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN | 2.61e-04 | 274 | 119 | 7 | M289 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | COL5A1 LAMA2 ADAM12 SSC5D FAT1 LIMS1 FBN1 PAPPA LTBP2 SNX9 NOTCH2 | 2.80e-04 | 681 | 119 | 11 | M39175 |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_DN | 3.11e-04 | 200 | 119 | 6 | M9337 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_DN | 3.11e-04 | 200 | 119 | 6 | M3826 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | COL4A5 SEMA3C PCDHGB7 DOCK8 KAT6A DLL1 AHDC1 GREB1L THBS3 FAT1 SCUBE1 FBN1 ZNF516 LRP2 IQCJ-SCHIP1 LTBP2 GNB3 AGRN UNC5D NOTCH2 | 1.06e-06 | 1075 | 114 | 20 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL4A5 ELAPOR2 SEMA3C ZNF154 PCDHGB7 DOCK8 KAT6A GTF2IRD1 DLL1 AHDC1 GREB1L THBS3 SCUBE1 FBN1 FBN2 EPHA2 ZNF516 PKD1 LRP2 LTBP2 GNB3 AGRN NOTCH2 | 2.75e-06 | 1466 | 114 | 23 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | CACNA2D1 SEMA3C LAMA2 ADAM12 GREB1L SCUBE1 FBN1 FBN2 LRP1 COL14A1 NOTCH2 | 3.48e-06 | 356 | 114 | 11 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | CHL1 ZHX3 CACNA2D1 ADAMTSL1 MYCBP2 FAM13C DOCK8 TF DST TLR4 WSCD2 TMPRSS2 PAPPA COL14A1 LTBP2 AGRN | 3.71e-06 | 772 | 114 | 16 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | SEMA3C PCDHGB7 KAT6A DLL1 AHDC1 ADD2 GREB1L ABLIM1 THBS3 FAT1 SCUBE1 FBN1 LRP2 IQCJ-SCHIP1 LTBP2 GNB3 UNC5D NOTCH2 | 3.90e-06 | 967 | 114 | 18 | PCBC_ratio_ECTO_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_1000 | ZHX3 CACNA2D1 SEMA3C EAF2 MYCBP2 GC SLC34A3 DLL1 GREB1L MET RANBP3L LRP2 TMPRSS2 AGRN IL17RB | 1.33e-05 | 758 | 114 | 15 | gudmap_developingKidney_e15.5_Proximal Tubules_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | COL5A1 CACNA2D1 SEMA3C ADAMTSL1 LAMA2 KCP FBXL17 GREB1L SNED1 MET THBS3 FAT1 FBN1 FBN2 DST SEMA5B PAPPA COL14A1 PSD4 | 1.37e-05 | 1166 | 114 | 19 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.60e-05 | 149 | 114 | 7 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | CACNA2D1 ADAMTSL1 MARCHF2 KCP DLL1 HESX1 GREB1L SNED1 MET ABLIM1 SCUBE1 BCL11B SEMA5B LRP2 COL14A1 UNC5D PSD4 | 1.77e-05 | 976 | 114 | 17 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | COL4A5 ZHX3 CACNA2D1 SEMA3C MYCBP2 DOCK8 DLL1 GREB1L LIMS1 DST LRP2 TMPRSS2 COL14A1 PRDM16 AGRN | 2.31e-05 | 795 | 114 | 15 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_adult_bladder_emap-29457_top-relative-expression-ranked_500 | CHL1 CACNA2D1 ADAMTSL1 FAM13C DOCK8 TF DST TLR4 WSCD2 TMPRSS2 | 3.74e-05 | 378 | 114 | 10 | gudmap_developingLowerUrinaryTract_adult_bladder_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_500 | 4.76e-05 | 389 | 114 | 10 | gudmap_developingKidney_e15.5_Proximal Tubules_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | CACNA2D1 ADAMTSL1 MARCHF2 KCP SNED1 MET BCL11B SEMA5B COL14A1 UNC5D PSD4 | 6.58e-05 | 489 | 114 | 11 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | CACNA2D1 SEMA3C LAMA2 IDI1 ADAM12 GREB1L FAT1 SCUBE1 FBN1 FBN2 LRP1 PAPPA COL14A1 NOTCH2 | 6.87e-05 | 773 | 114 | 14 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_1000 | ZHX3 CACNA2D1 ADAMTSL1 FAM13C DOCK8 ADAM12 TF DST TLR4 TMPRSS2 COL14A1 LTBP2 PRDM16 AGRN | 6.96e-05 | 774 | 114 | 14 | gudmap_developingLowerUrinaryTract_P1_ureter_1000 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | 7.08e-05 | 408 | 114 | 10 | gudmap_kidney_adult_RenalCapsule_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#3_top-relative-expression-ranked_500 | 8.02e-05 | 82 | 114 | 5 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_500 | CHL1 ZHX3 CACNA2D1 ADAMTSL1 FAM13C SLCO3A1 SNED1 FBN2 TLR4 PAPPA | 9.17e-05 | 421 | 114 | 10 | gudmap_developingKidney_e15.5_Peripheral blastema_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | CHL1 CACNA2D1 ADAMTSL1 MYCBP2 FAM13C ADAM12 SLC7A14 LIMS1 BCL11B FBN2 TMPRSS2 COL14A1 AGRN ZNF646 | 1.25e-04 | 818 | 114 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500 | 1.29e-04 | 207 | 114 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.36e-04 | 280 | 114 | 8 | gudmap_developingKidney_e15.5_Proximal Tubules_1000_k5 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200 | 1.38e-04 | 146 | 114 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#2_top-relative-expression-ranked_500 | 1.62e-04 | 51 | 114 | 4 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | CACNA2D1 ADAMTSL1 MARCHF2 KCP IDI1 GTF2IRD1 SNED1 MET BCL11B SEMA5B COL14A1 PRDM16 MUC6 UNC5D PSD4 | 2.34e-04 | 978 | 114 | 15 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchSmoothMuscl_top-relative-expression-ranked_1000 | CPA4 SEMA3C ADAMTSL1 ADAM12 SLC7A14 SNED1 SSC5D AHRR FBN1 IL21R LRP1 PAPPA COL14A1 LTBP2 SNX9 | 2.42e-04 | 981 | 114 | 15 | PCBC_ctl_BronchSmoothMuscl_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | EPHB4 COL5A1 CACNA2D1 ADAMTSL1 ZNF175 LAMA2 KCP GREB1L THBS3 FAT1 FBN1 FBN2 SEMA5B PKD1 ZNF667 LRP1 PAPPA | 2.42e-04 | 1208 | 114 | 17 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000 | ZHX3 CACNA2D1 SEMA3C MYCBP2 FAM13C LAMA2 LIMS1 BCL11B FBN2 DST PAPPA COL14A1 AGRN | 2.58e-04 | 772 | 114 | 13 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_500 | 2.78e-04 | 394 | 114 | 9 | gudmap_developingLowerUrinaryTract_e15.5_urothelium_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 2.99e-04 | 398 | 114 | 9 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_500 | SEMA3C ADAMTSL1 ADAM12 SNED1 SSC5D AHRR FBN1 TLR4 PAPPA LTBP2 | 3.28e-04 | 493 | 114 | 10 | PCBC_ctl_CardiacMyocyte_500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.52e-04 | 244 | 114 | 7 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500 | 3.97e-04 | 249 | 114 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3 | 3.97e-04 | 249 | 114 | 7 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_top-relative-expression-ranked_500 | CHL1 CACNA2D1 ADAMTSL1 FAM13C ADAM12 LIMS1 TMPRSS2 COL14A1 AGRN | 4.50e-04 | 421 | 114 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_top-relative-expression-ranked_500 | CHL1 ZHX3 CACNA2D1 ADAMTSL1 FAM13C ADAM12 TLR4 TMPRSS2 COL14A1 | 4.58e-04 | 422 | 114 | 9 | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-6668_500 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.65e-04 | 336 | 114 | 8 | ratio_EB_vs_SC_1000_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.95e-04 | 121 | 114 | 5 | gudmap_developingLowerUrinaryTract_P1_ureter_1000_k1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#1_top-relative-expression-ranked_1000 | 5.33e-04 | 123 | 114 | 5 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k1 | |
| CoexpressionAtlas | gudmap_RNAseq_p2_CD2APMEISWT_2500_K4 | CACNA2D1 FAM13C DOCK8 SLCO3A1 ADAM12 TF HESX1 ADD2 SNED1 FAT1 FBN1 TLR4 LRP1 | 5.89e-04 | 842 | 114 | 13 | gudmap_RNAseq_p2_CD2APMEISWT_2500_K4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_1000 | 6.45e-04 | 73 | 114 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k2 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_1000 | 6.51e-04 | 195 | 114 | 6 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500 | 6.67e-04 | 32 | 114 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | CACNA2D1 ADAMTSL1 MARCHF2 LAMA2 KCP IDI1 DLL1 SNED1 BCL11B FBN1 KCNH2 COL14A1 LTBP2 MUC6 | 7.20e-04 | 973 | 114 | 14 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | 7.44e-04 | 361 | 114 | 8 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | COL5A1 ADAMTSL1 FAM13C KCP ADAM12 TF GREB1L SSC5D THBS3 SCUBE1 FBN1 FBN2 LRP2 PAPPA LTBP2 | 7.57e-04 | 1094 | 114 | 15 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.60e-04 | 133 | 114 | 5 | gudmap_developingKidney_e15.5_1000_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500 | 7.85e-04 | 364 | 114 | 8 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#2 | 7.86e-04 | 134 | 114 | 5 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K2 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | CACNA2D1 SEMA3C ADAMTSL1 MET FBN1 LRP2 TMPRSS2 PRDM16 NOTCH2 | 7.96e-04 | 456 | 114 | 9 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | CACNA2D1 ADAMTSL1 MARCHF2 KCP DLL1 SNED1 MET ABLIM1 BCL11B SEMA5B LRP2 COL14A1 PRDM16 PSD4 | 8.04e-04 | 984 | 114 | 14 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | COL5A1 SEMA3C KCP DLL1 ADAM12 TF SCUBE1 SEMA5B LRP2 WSCD2 TMPRSS2 SRL PAPPA COL14A1 | 8.20e-04 | 986 | 114 | 14 | PCBC_EB_fibroblast_1000 |
| CoexpressionAtlas | Myeloid Cells, MF.RP.Sp, F4/80hi CD11blo CD11c- autofluorescent, Spleen, avg-3 | 8.28e-04 | 78 | 114 | 4 | GSM605853_100 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | 8.57e-04 | 369 | 114 | 8 | gudmap_kidney_adult_RenalCapsule_k2_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 | EPHB4 COL5A1 CACNA2D1 ADAMTSL1 KCP GREB1L SNED1 THBS3 FAT1 SCUBE1 BCL11B FBN1 FBN2 PKD1 LRP1 PAPPA | 8.63e-04 | 1228 | 114 | 16 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | CACNA2D1 SEMA3C LAMA2 ADAM12 GREB1L FAT1 SCUBE1 FBN1 FBN2 LRP1 COL14A1 NOTCH2 | 8.70e-04 | 768 | 114 | 12 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#3_top-relative-expression-ranked_200 | 8.70e-04 | 35 | 114 | 3 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_200_k3 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | CHL1 SEMA3C ADAMTSL1 ADAM12 TF GREB1L SCUBE1 SEMA5B LRP2 WSCD2 TMPRSS2 SRL PAPPA COL14A1 | 8.86e-04 | 994 | 114 | 14 | PCBC_EB_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_1000 | CPA4 COL5A1 SEMA3C FAM13C CLIC3 ADAM12 TF SSC5D FBN1 TLR4 SRL PAPPA LTBP2 PRDM16 | 8.86e-04 | 994 | 114 | 14 | PCBC_ratio_EB_vs_SC_1000 |
| CoexpressionAtlas | Mesoderm Day 30-method_NA_vs_Mesoderm Day 30-method_episomal-Confounder_removed-fold2.0_adjp0.05 | 8.89e-04 | 207 | 114 | 6 | PCBC_ratio_MESO-30_from-ESC_vs_MESO-30_from-episomal_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30-reprogram_NA_vs_Mesoderm Day 30-reprogram_OSK-L-l-p53KD-Confounder_removed-fold2.0_adjp0.05 | 8.89e-04 | 207 | 114 | 6 | PCBC_ratio_MESO-30_from-ESC_vs_MESO-30_from-OSK-L-l-p53KD_cfr-2X-p05 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | 8.99e-04 | 464 | 114 | 9 | JC_fibro_1000_K1 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | CACNA2D1 SEMA3C ADAMTSL1 LAMA2 ADAM12 GREB1L SCUBE1 FBN1 FBN2 LRP1 COL14A1 NOTCH2 | 9.62e-04 | 777 | 114 | 12 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200 | 9.99e-04 | 82 | 114 | 4 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#5_top-relative-expression-ranked_500 | 9.99e-04 | 82 | 114 | 4 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_500 | 1.03e-03 | 37 | 114 | 3 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | 1.14e-03 | 298 | 114 | 7 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.15e-03 | 146 | 114 | 5 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_ureter_emap-30363_top-relative-expression-ranked_500 | 1.22e-03 | 390 | 114 | 8 | gudmap_developingLowerUrinaryTract_P1_ureter_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.23e-03 | 148 | 114 | 5 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_1000 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COL5A1 SEMA3C LAMA2 LBHD2 SSC5D THBS3 FBN1 COL14A1 LTBP2 GNB3 | 8.29e-11 | 183 | 121 | 10 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.74e-11 | 184 | 121 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.74e-11 | 184 | 121 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.74e-11 | 184 | 121 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | COL5A1 CACNA2D1 SEMA3C LAMA2 SNED1 SSC5D FAT1 FBN1 PAPPA LTBP2 | 1.14e-10 | 189 | 121 | 10 | 44e37f88137bb249933eb615235b2cf2ae7f3925 |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | COL5A1 CACNA2D1 LAMA2 ADAM12 SNED1 FBN1 DST PAPPA COL14A1 LTBP2 | 1.71e-10 | 197 | 121 | 10 | f1c8936986123a3151140c374fcd62d6705c530b |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | COL5A1 CACNA2D1 LAMA2 ADAM12 SNED1 FBN1 DST PAPPA COL14A1 LTBP2 | 1.71e-10 | 197 | 121 | 10 | fb847f2277609c31fffcdf49517243ce0684facf |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | COL5A1 CACNA2D1 LAMA2 ADAM12 SNED1 FBN1 DST PAPPA COL14A1 LTBP2 | 1.80e-10 | 198 | 121 | 10 | df3de77216f5c5d6141ec44d01c56b942f611838 |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.16e-09 | 173 | 121 | 9 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | (2)_Fibroblasts-(20)_Fibro-1|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.42e-09 | 188 | 121 | 9 | 409a7b69d02e87084ca955e3fe6c77230dee8861 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-09 | 189 | 121 | 9 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-09 | 192 | 121 | 9 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 3.05e-09 | 193 | 121 | 9 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.19e-09 | 194 | 121 | 9 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.33e-09 | 195 | 121 | 9 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.81e-09 | 198 | 121 | 9 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.81e-09 | 198 | 121 | 9 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.98e-09 | 199 | 121 | 9 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.98e-09 | 199 | 121 | 9 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.98e-09 | 199 | 121 | 9 | 6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.16e-09 | 200 | 121 | 9 | 747c61d4e0b746278ae1f45ca4cd556c6961c76a | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|Control_saline / Treatment groups by lineage, cell group, cell type | 4.16e-09 | 200 | 121 | 9 | a799fc7bb83ad0524362cb5010df949741fb7bf3 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.16e-09 | 200 | 121 | 9 | 09537dc25f8b8b4654a7c183827ee1522a41a4e0 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.16e-09 | 200 | 121 | 9 | de1d193f773f4e2927baa6fc38d29754b015c6e6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.76e-08 | 175 | 121 | 8 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.44e-08 | 180 | 121 | 8 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.59e-08 | 181 | 121 | 8 | 6956ecd6264f7469a25e555673bce4eb97d28f7a | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.25e-08 | 185 | 121 | 8 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-08 | 186 | 121 | 8 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-08 | 187 | 121 | 8 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-08 | 187 | 121 | 8 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.62e-08 | 187 | 121 | 8 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.62e-08 | 187 | 121 | 8 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 4.81e-08 | 188 | 121 | 8 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.22e-08 | 190 | 121 | 8 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.44e-08 | 191 | 121 | 8 | b51e0f5d1b93f526160c904e9091313a5364f3a7 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-08 | 192 | 121 | 8 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.66e-08 | 192 | 121 | 8 | 321850b0f881420c2d57d3e825e365c82fa511ab | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-08 | 192 | 121 | 8 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-08 | 192 | 121 | 8 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-08 | 192 | 121 | 8 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-08 | 192 | 121 | 8 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.66e-08 | 192 | 121 | 8 | cf2765d8bc074f7f9ee864eae632a3b705175842 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.66e-08 | 192 | 121 | 8 | 0dc1f46e40346ed0b286e53b106a812441575100 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.14e-08 | 194 | 121 | 8 | f44394c8a6f86483063f2f5722f003a8a0a70254 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.14e-08 | 194 | 121 | 8 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.38e-08 | 195 | 121 | 8 | 79a6e8e6de040ff07539e8901fc407363a50e355 | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-08 | 196 | 121 | 8 | ad1838dabd043cb140260843e3527d8c7d58850e | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-08 | 196 | 121 | 8 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-08 | 196 | 121 | 8 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-08 | 196 | 121 | 8 | cbc15c0769016fe9972445169029bd8d14a7e6ef | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.91e-08 | 197 | 121 | 8 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.91e-08 | 197 | 121 | 8 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.91e-08 | 197 | 121 | 8 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.91e-08 | 197 | 121 | 8 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.91e-08 | 197 | 121 | 8 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.91e-08 | 197 | 121 | 8 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.91e-08 | 197 | 121 | 8 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.91e-08 | 197 | 121 | 8 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.18e-08 | 198 | 121 | 8 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.18e-08 | 198 | 121 | 8 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.18e-08 | 198 | 121 | 8 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-08 | 198 | 121 | 8 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 7.18e-08 | 198 | 121 | 8 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.47e-08 | 199 | 121 | 8 | 40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 7.47e-08 | 199 | 121 | 8 | e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.47e-08 | 199 | 121 | 8 | 9672230aa0bc6a7289050c955f5154ca183a5159 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.47e-08 | 199 | 121 | 8 | e18abe678da293bd01fae55e2f9ab6fdd643d02d | |
| ToppCell | metastatic_Brain-Fibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 7.47e-08 | 199 | 121 | 8 | 63eb2106bb6e2e33d020628583536c8d96662c84 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.47e-08 | 199 | 121 | 8 | 1fd7bbb8727607e6507848602a19bc86882ef2d5 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.76e-08 | 200 | 121 | 8 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.76e-08 | 200 | 121 | 8 | fee22a6a6c7b93af204b5b56f2c34f1411500e18 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.76e-08 | 200 | 121 | 8 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Myofibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 7.76e-08 | 200 | 121 | 8 | 9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.76e-08 | 200 | 121 | 8 | 8ab0051544ea32eb8b3f7f8ba7582deaf8bf26c0 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 7.76e-08 | 200 | 121 | 8 | 08bf8c00eee6468215edb3611296bfc8784c4d56 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.76e-08 | 200 | 121 | 8 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-07 | 160 | 121 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-07 | 160 | 121 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.35e-07 | 164 | 121 | 7 | 382e42701779d12a7948690b3be72d06dd75c8b4 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-07 | 169 | 121 | 7 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-07 | 169 | 121 | 7 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-07 | 169 | 121 | 7 | 8bfa2d3bb541d02f55d7c95b8fd156c8403befca | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.62e-07 | 172 | 121 | 7 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.19e-07 | 175 | 121 | 7 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.40e-07 | 176 | 121 | 7 | 08f94b78b27feeb113dbfadbfa7fe34d08b2809b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.61e-07 | 177 | 121 | 7 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.51e-07 | 181 | 121 | 7 | 25915e2500430a902db37d79a749ce2990b69810 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.51e-07 | 181 | 121 | 7 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.01e-07 | 183 | 121 | 7 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | COVID-19-kidney-CD-IC-A|kidney / Disease (COVID-19 only), tissue and cell type | 7.01e-07 | 183 | 121 | 7 | 5c7597a5b2bf6a481ca2c7e68560179214150fa0 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-07 | 184 | 121 | 7 | 3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-07 | 185 | 121 | 7 | 33cc0e9d8b54cb7408b51235f2a70e044ebae04d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.54e-07 | 185 | 121 | 7 | 87c416d14ca6255bee39b16e7571553e36ee3069 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.54e-07 | 185 | 121 | 7 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.54e-07 | 185 | 121 | 7 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 7.54e-07 | 185 | 121 | 7 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-07 | 185 | 121 | 7 | 9954fc85b183c1cc45c3c24e3dadc7984ee6f649 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-07 | 185 | 121 | 7 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.54e-07 | 185 | 121 | 7 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| Computational | Adhesion molecules. | 2.17e-06 | 141 | 66 | 8 | MODULE_122 | |
| Computational | Metal / Ca ion binding. | 1.58e-04 | 133 | 66 | 6 | MODULE_324 | |
| Computational | Ovary genes. | 3.86e-04 | 368 | 66 | 9 | MODULE_1 | |
| Drug | LMWH | COL4A5 COL5A1 ACR LAMA2 GC ADAM12 MET THBS3 DST LRP1 LRP2 PAPPA COL14A1 AGRN | 7.98e-06 | 663 | 117 | 14 | CID000000772 |
| Drug | Pargyline hydrochloride [306-07-0]; Up 200; 20.4uM; HL60; HG-U133A | 8.00e-06 | 196 | 117 | 8 | 1418_UP | |
| Drug | Pralidoxime chloride [51-15-0]; Down 200; 23.2uM; MCF7; HT_HG-U133A | 8.62e-06 | 198 | 117 | 8 | 5383_DN | |
| Drug | Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 8.94e-06 | 199 | 117 | 8 | 2747_UP | |
| Drug | Epiandrosterone [481-29-8]; Down 200; 13.8uM; PC3; HT_HG-U133A | 9.27e-06 | 200 | 117 | 8 | 4626_DN | |
| Drug | pyrachlostrobin | COL4A5 COL5A1 SSC5D FAT1 SCUBE1 FBN1 EPHA2 ZNF516 TLR4 LRP2 PAPPA LTBP2 PRDM16 EPHA10 NOTCH2 | 1.78e-05 | 811 | 117 | 15 | ctd:C513428 |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.95e-06 | 53 | 114 | 5 | C4707243 | |
| Disease | cortical surface area measurement | CPA4 FNIP2 ZHX3 CACNA2D1 SEMA3C ADAMTSL1 ZAN MYCBP2 LAMA2 FBXL17 ADAM12 SCUBE1 BCL11B FBN1 FBN2 PKD1 WSCD2 PAPPA | 4.05e-06 | 1345 | 114 | 18 | EFO_0010736 |
| Disease | intraocular pressure measurement | COL5A1 SEMA3C FBXL17 ADAM12 FBN1 FBN2 RANBP3L ZNF516 LTBP2 PRDM16 | 2.93e-05 | 509 | 114 | 10 | EFO_0004695 |
| Disease | Weill-Marchesani syndrome | 4.43e-05 | 3 | 114 | 2 | C0265313 | |
| Disease | connective tissue disease (implicated_via_orthology) | 4.43e-05 | 3 | 114 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | Weill-Marchesani Syndrome, Autosomal Dominant | 4.43e-05 | 3 | 114 | 2 | C1869115 | |
| Disease | Weill-Marchesani Syndrome, Autosomal Recessive | 4.43e-05 | 3 | 114 | 2 | C1869114 | |
| Disease | scoliosis (is_implicated_in) | 8.83e-05 | 4 | 114 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | Weill-Marchesani syndrome | 8.83e-05 | 4 | 114 | 2 | cv:C0265313 | |
| Disease | Short QT Syndrome 1 | 8.83e-05 | 4 | 114 | 2 | C1865020 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 8.83e-05 | 4 | 114 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | cortical thickness | CPA4 FNIP2 ZHX3 MYCBP2 LAMA2 ADAM12 THBS3 SCUBE1 BCL11B FBN1 FBN2 PKD1 LRP1 IQCJ-SCHIP1 | 1.02e-04 | 1113 | 114 | 14 | EFO_0004840 |
| Disease | nicotine dependence symptom count | 1.24e-04 | 285 | 114 | 7 | EFO_0009262 | |
| Disease | Endometrial Stromal Sarcoma | 1.47e-04 | 5 | 114 | 2 | C0206630 | |
| Disease | Schizophrenia | CHL1 LAMA2 GC ADAM12 TF MET ZNF530 KCNH2 TLR4 LRP1 LRP2 GNB3 | 1.62e-04 | 883 | 114 | 12 | C0036341 |
| Disease | serum IgG glycosylation measurement | 2.01e-04 | 523 | 114 | 9 | EFO_0005193 | |
| Disease | Clear cell sarcoma of kidney | 2.20e-04 | 6 | 114 | 2 | C0334488 | |
| Disease | concentration dose ratio, response to antipsychotic drug | 2.20e-04 | 6 | 114 | 2 | EFO_0007635, GO_0097332 | |
| Disease | cancer antigen 15.3 measurement | 3.07e-04 | 7 | 114 | 2 | EFO_0010585 | |
| Disease | Lymphoma | 5.00e-04 | 40 | 114 | 3 | C0024299 | |
| Disease | Acute Confusional Migraine | 5.23e-04 | 9 | 114 | 2 | C0521664 | |
| Disease | Status Migrainosus | 5.23e-04 | 9 | 114 | 2 | C0338489 | |
| Disease | Abdominal Migraine | 5.23e-04 | 9 | 114 | 2 | C0270858 | |
| Disease | Sick Headaches | 5.23e-04 | 9 | 114 | 2 | C0700438 | |
| Disease | arthritis (is_implicated_in) | 5.23e-04 | 9 | 114 | 2 | DOID:848 (is_implicated_in) | |
| Disease | Cervical Migraine Syndrome | 5.23e-04 | 9 | 114 | 2 | C0007852 | |
| Disease | Hemicrania migraine | 5.23e-04 | 9 | 114 | 2 | C0018984 | |
| Disease | Acute kidney injury | 6.47e-04 | 101 | 114 | 4 | C2609414 | |
| Disease | Acute Kidney Insufficiency | 6.47e-04 | 101 | 114 | 4 | C1565662 | |
| Disease | Kidney Failure, Acute | 6.47e-04 | 101 | 114 | 4 | C0022660 | |
| Disease | aortic aneurysm | 6.52e-04 | 10 | 114 | 2 | EFO_0001666 | |
| Disease | otitis media (is_marker_for) | 6.52e-04 | 10 | 114 | 2 | DOID:10754 (is_marker_for) | |
| Disease | hepatocyte growth factor measurement | 6.63e-04 | 44 | 114 | 3 | EFO_0006903 | |
| Disease | Gastric Adenocarcinoma | 7.08e-04 | 45 | 114 | 3 | C0278701 | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 7.95e-04 | 11 | 114 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | Shortened QT interval | 7.95e-04 | 11 | 114 | 2 | C0151879 | |
| Disease | Marfan Syndrome | 7.95e-04 | 11 | 114 | 2 | C0024796 | |
| Disease | multiple sclerosis (is_marker_for) | 9.09e-04 | 49 | 114 | 3 | DOID:2377 (is_marker_for) | |
| Disease | collagen disease (implicated_via_orthology) | 9.52e-04 | 12 | 114 | 2 | DOID:854 (implicated_via_orthology) | |
| Disease | cognitive inhibition measurement | 9.64e-04 | 50 | 114 | 3 | EFO_0007969 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | LAMA2 FBXL17 FAM135B MET TLR4 SNTG1 WSCD2 IQCJ-SCHIP1 USH2A TET3 | 1.10e-03 | 801 | 114 | 10 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | Migraine Disorders | 1.12e-03 | 13 | 114 | 2 | C0149931 | |
| Disease | Abnormality of refraction | 1.23e-03 | 673 | 114 | 9 | HP_0000539 | |
| Disease | Metabolic Bone Disorder | 1.31e-03 | 14 | 114 | 2 | C0005944 | |
| Disease | Osteopenia | 1.50e-03 | 15 | 114 | 2 | C0029453 | |
| Disease | eye colour measurement | 1.61e-03 | 218 | 114 | 5 | EFO_0009764 | |
| Disease | Colorectal Carcinoma | 1.64e-03 | 702 | 114 | 9 | C0009402 | |
| Disease | temporal arteritis (is_implicated_in) | 1.71e-03 | 16 | 114 | 2 | DOID:13375 (is_implicated_in) | |
| Disease | corneal resistance factor | 1.88e-03 | 451 | 114 | 7 | EFO_0010067 | |
| Disease | pelvic organ prolapse | 1.95e-03 | 136 | 114 | 4 | EFO_0004710 | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.97e-03 | 64 | 114 | 3 | DOID:4947 (is_marker_for) | |
| Disease | Headache | 1.97e-03 | 64 | 114 | 3 | HP_0002315 | |
| Disease | Coronary Arteriosclerosis | 2.06e-03 | 65 | 114 | 3 | C0010054 | |
| Disease | Coronary Artery Disease | 2.06e-03 | 65 | 114 | 3 | C1956346 | |
| Disease | sinusitis (is_marker_for) | 2.17e-03 | 18 | 114 | 2 | DOID:0050127 (is_marker_for) | |
| Disease | abnormal paneth cell measurement | 2.42e-03 | 19 | 114 | 2 | EFO_0007963 | |
| Disease | total cholesterol measurement, hematocrit, stroke, ventricular rate measurement, body mass index, atrial fibrillation, high density lipoprotein cholesterol measurement, coronary artery disease, diastolic blood pressure, triglyceride measurement, systolic blood pressure, heart failure, diabetes mellitus, glucose measurement, mortality, cancer | 2.44e-03 | 69 | 114 | 3 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004340, EFO_0004348, EFO_0004352, EFO_0004468, EFO_0004530, EFO_0004574, EFO_0004612, EFO_0006335, EFO_0006336, EFO_0007928, MONDO_0004992 | |
| Disease | unipolar depression | ZHX3 CACNA2D1 SEMA3C ADAMTSL1 MARCHF2 GC MUC5B FAM135B FAT1 TLR4 PKD1 LTBP2 | 2.46e-03 | 1206 | 114 | 12 | EFO_0003761 |
| Disease | alpha-tocopherol measurement | 2.69e-03 | 20 | 114 | 2 | EFO_0007898 | |
| Disease | Prostatic Neoplasms | 2.74e-03 | 616 | 114 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.74e-03 | 616 | 114 | 8 | C0376358 | |
| Disease | waist-hip ratio | COL5A1 ZHX3 SEMA3C TCF15 MYCBP2 SLCO3A1 SSC5D PKD1 WSCD2 COL14A1 LTBP2 PRDM16 | 2.81e-03 | 1226 | 114 | 12 | EFO_0004343 |
| Disease | pulse pressure measurement | EPHB4 FBXL17 AHDC1 MET FBN1 FBN2 ZNF516 PKD1 LRP1 SNTG1 IQCJ-SCHIP1 LTBP2 PRDM16 | 2.82e-03 | 1392 | 114 | 13 | EFO_0005763 |
| Disease | FEV/FEC ratio | FBXL17 GTF2IRD1 ADAM12 MET THBS3 FBN1 FCGBP DST ZNF516 LRP1 LTBP2 PRDM16 | 2.85e-03 | 1228 | 114 | 12 | EFO_0004713 |
| Disease | neuroimaging measurement | ZHX3 LAMA2 TF ABLIM1 BCL11B FBN2 TLR4 PKD1 PAPPA IQCJ-SCHIP1 PRDM16 | 2.89e-03 | 1069 | 114 | 11 | EFO_0004346 |
| Disease | Antimigraine preparation use measurement | 2.96e-03 | 21 | 114 | 2 | EFO_0009939 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 2.98e-03 | 74 | 114 | 3 | DOID:3748 (is_marker_for) | |
| Disease | carotid artery disease (is_implicated_in) | 3.25e-03 | 22 | 114 | 2 | DOID:3407 (is_implicated_in) | |
| Disease | Glioblastoma | 3.59e-03 | 79 | 114 | 3 | C0017636 | |
| Disease | dyslexia | 3.66e-03 | 162 | 114 | 4 | EFO_0005424 | |
| Disease | Lung Neoplasms | 3.73e-03 | 265 | 114 | 5 | C0024121 | |
| Disease | Carcinomatosis | 3.74e-03 | 163 | 114 | 4 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 3.74e-03 | 163 | 114 | 4 | C0205697 | |
| Disease | Undifferentiated carcinoma | 3.74e-03 | 163 | 114 | 4 | C0205698 | |
| Disease | Anaplastic carcinoma | 3.74e-03 | 163 | 114 | 4 | C0205696 | |
| Disease | Malignant neoplasm of lung | 3.79e-03 | 266 | 114 | 5 | C0242379 | |
| Disease | Carcinoma | 3.82e-03 | 164 | 114 | 4 | C0007097 | |
| Disease | Brugada Syndrome (disorder) | 3.86e-03 | 24 | 114 | 2 | C1142166 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KDSGCEGAADGCVPS | 541 | A9YTQ3 | |
| GGEAASTFSKDPSGC | 16 | Q6ZRV3 | |
| STFSKDPSGCCVGND | 21 | Q6ZRV3 | |
| SPKETTFSSNCAGCG | 216 | O14639 | |
| SVVAKDNATCDGPCG | 16 | P10323 | |
| KASEDGESVGHCPSC | 11 | O95833 | |
| TSGEPITNFGVCSCS | 1836 | Q86UK0 | |
| GCCSDGKTPSLDAEG | 1111 | O00468 | |
| KPAGTACRDSSNSCD | 476 | O43184 | |
| PFTGQDCANSKDCSF | 986 | Q5TGY3 | |
| LDCSNSSAGTPGAEC | 801 | Q9HC84 | |
| VNITFCEGSCPGASK | 5676 | Q9HC84 | |
| CEGSCPGASKYSAEA | 5681 | Q9HC84 | |
| GPSTNGCQFFITCSK | 116 | O43447 | |
| NSSCGAFGPCTEKNS | 286 | Q8N130 | |
| PTAGDCFESVLCSKS | 721 | Q9Y5F8 | |
| SPGCFLTATEDCASN | 4006 | Q14517 | |
| SSENKFGAACAPTCQ | 776 | Q6W4X9 | |
| GKATCRCASGFTGED | 86 | P0DPK3 | |
| GKATCRCASGFTGED | 86 | Q04721 | |
| EEAPCCSSSVSGGAA | 36 | O15479 | |
| GSLCDCSGSPAFSKV | 11 | Q9P0N8 | |
| CTSQGCGKPITEESS | 996 | O00533 | |
| TGCSCAPGFEAAEGN | 251 | P54760 | |
| CAQGTFKPLSGEGSC | 271 | P54760 | |
| ENSSCKACGSTEDGN | 411 | Q9H3C7 | |
| CNDFPSHLECTSGSK | 3361 | Q03001 | |
| AAHCEGKTCGPSSFS | 2766 | Q07954 | |
| NSVCDGTCGKSEGSP | 401 | Q9NRM6 | |
| DCEKSSDTCNPLSGA | 976 | Q12809 | |
| FTKCSESCGGGVQEA | 616 | Q8N6G6 | |
| SACGEPSGTRCFAQS | 401 | Q9BUK6 | |
| ADTCSSSGKDGNLCL | 46 | Q9UBX0 | |
| GADEKNCFSCQPGTF | 446 | O75074 | |
| PNGEAICTGSDDASC | 236 | P16520 | |
| SFGSKSFDCEESGQC | 971 | P24043 | |
| GKAADNAGSECACSE | 86 | A0A0U1RRK4 | |
| CACPQGSSFIEGSTT | 4351 | P98164 | |
| DCSSIPGAAGTCKET | 111 | Q5JZY3 | |
| ASFSCPEGTTFGSQC | 1296 | Q13219 | |
| PEGSCTTDGFCQAGK | 111 | Q9C091 | |
| DPVRGKECTFSCASG | 96 | A8MWY0 | |
| ADCGNSGHPSCLKFS | 231 | Q92794 | |
| SSKDSCQDTAGNCPE | 101 | Q96QU4 | |
| SSKDSCQDTAGNCPE | 101 | Q64ET8 | |
| SDAKITFPGCFTNTC | 71 | Q13907 | |
| FGCQCQLSGKDEPSS | 206 | Q9C0K0 | |
| CDVSGKGPVTACDFD | 186 | Q8NF50 | |
| DCKSSTSDTGNCVSG | 201 | Q96CJ1 | |
| ANDCLDSFASPSGCG | 321 | Q6ZMU1 | |
| DSKSFSGVLDCGNCS | 986 | P54289 | |
| SSPCSNGAKCVDLGD | 411 | O00548 | |
| SFSCCSGFLDGMPSE | 66 | Q8NCQ5 | |
| CVAVGSTTCQASGDP | 3646 | Q9Y6R7 | |
| NTEGSFKCLCPEGFS | 2031 | P35555 | |
| CSCSETNEVALGPAG | 1451 | Q05707 | |
| SEACSAGCLGPASDA | 626 | Q9P278 | |
| TVRDCNSFPGGASSC | 101 | P29317 | |
| AASASSPASCCKELG | 131 | Q9UF56 | |
| ASFAGKGASDNPCSE | 261 | Q9UI42 | |
| GNTTTGERATCCFPS | 206 | Q9HC77 | |
| DKGDTCFNCIGTGIS | 476 | P29400 | |
| FPDSNSGCLGDTQFC | 101 | Q8IWF6 | |
| CNFTAGGSTCVFPDK | 1671 | P20908 | |
| TEGSFNCLCETGFQP | 1236 | Q14767 | |
| DSGFVGSDCSSPVEC | 491 | Q9HBE5 | |
| SCSQLCGDSGTDAGA | 811 | Q49AJ0 | |
| GSFNCECSPGSKLSS | 871 | P35556 | |
| SSKNPCNYGCSNTEG | 2701 | P35556 | |
| TGAQDFSDCCGQKPT | 296 | Q9UHL9 | |
| SECGGQCSPGFFSAD | 681 | Q8IWY4 | |
| QPEACSAFCFSTGQG | 206 | P98161 | |
| NCGGSPSSSCKEAVT | 26 | O95868 | |
| PSSSCKEAVTTCGEG | 31 | O95868 | |
| PSGRSFCCESEGQFK | 6 | Q8IVF1 | |
| PSGRSFCCESEGQFK | 6 | A6NNL0 | |
| PSGRSFCCESEGQFK | 6 | B1AL46 | |
| FPCQDCSSKANLSGG | 96 | P08581 | |
| DCDTAGSLPGTVCNA | 796 | O75445 | |
| FVTGSKCDACVPSAS | 1026 | O75445 | |
| EACTSKGCSLSPESQ | 2601 | O75445 | |
| PSDGKDQFSCGNSVA | 61 | Q9Y5X1 | |
| DSKCESGKGRCSFNP | 156 | Q99985 | |
| ECQTDSFTPVCGADG | 476 | Q9UIG8 | |
| NEDCACAPSDQSSGT | 151 | Q9NSN8 | |
| GNGETFSPDACTTCR | 146 | Q6ZWJ8 | |
| HACPDCGKTFATSSG | 366 | Q9HAZ2 | |
| FLASPCSENSASGEC | 251 | Q8NDX1 | |
| GKPTTSSSEACRFCG | 4346 | O75592 | |
| SPCLAGCKSSSGNKE | 436 | G3V0H7 | |
| SSSRCSCGDGKEPQT | 271 | Q8NE31 | |
| ASATCERCKGGFAPA | 6 | P48059 | |
| CSECKSSSSPGGSLD | 131 | B3KU38 | |
| CKGSEASLSDCPSGA | 841 | A1L4H1 | |
| FGGPTCETAQSPCDT | 341 | Q8TER0 | |
| EKGSSCFPVDTTGFC | 196 | P35612 | |
| KCPDCGESFSQSFNL | 441 | Q7Z3I7 | |
| DEFSGPATNTCGAKN | 471 | Q8TBB6 | |
| ECNECGKAFSSGSDL | 556 | Q5HYK9 | |
| SDASDQSFGCCEGPE | 31 | Q12870 | |
| AATTGQGKSSECFEC | 506 | Q92618 | |
| PFTCSVCGKGFSQSA | 221 | P13682 | |
| TGERPFVCSECGKSF | 306 | Q6ZN11 | |
| PTICGECGKSFRQSS | 191 | Q96MX3 | |
| CPECGKGFADSSARV | 481 | Q96MX3 | |
| SSGPERFSCATCGQS | 786 | P0CJ78 | |
| SGIECDSSGTCINPS | 116 | O15393 | |
| NFFSGSCAPCADGTD | 171 | P02787 | |
| NAKCDGTVDCPDGSD | 576 | Q7RTY8 | |
| ATSVGCQPNEDKCSF | 191 | Q86VV4 | |
| NPGALNCDKTGCSET | 451 | Q86TD4 | |
| DCVSSFNQDPSSCGE | 196 | Q9Y5U2 | |
| ETGLFPCTTCGKDFS | 71 | O15015 | |
| KGCQTEASSERPFSC | 1191 | O15015 | |
| CDVEDSTTCFNAKGP | 376 | P02774 | |
| EGFSGTACETCTEGK | 1376 | Q8WWQ8 | |
| FDASGECGSCVNTPS | 1896 | Q8WWQ8 | |
| SATGECKCNTGFNGT | 1981 | Q8WWQ8 | |
| TRTCPADGSGSCDTD | 821 | Q9P283 | |
| KDPNTCGASFSFGCS | 971 | O43151 | |
| GCDPNSICTNTVGSF | 381 | P49746 | |
| GKFCEGLSQESENCT | 341 | Q6UXZ4 | |
| ECSECGKGFSQNSDL | 426 | P51814 | |
| ECSQCGKAFSGSSNL | 661 | Q6NX49 | |
| PFECGECGKAFSQSA | 376 | P17020 | |
| QSPCVSDGICDAGFS | 286 | Q5VWN6 | |
| CSECGKSFSQSSGFL | 241 | Q6P9A1 | |
| ECSECGKVFSQSSGL | 436 | Q6P9A1 | |
| ECSECGKSFSQSSGL | 576 | Q6P9A1 | |
| ECSECGKSFTQNSGL | 386 | Q13106 | |
| AQKCSAEEFESCGTP | 301 | Q2TBF2 | |
| QTSSGLFCCGPASVK | 366 | Q96PF1 | |
| TDFNKDPTFVCSGCS | 101 | Q9H4I2 | |
| SFKGCCSQSDFGTTS | 386 | O00206 | |
| KKPDGCSECGGSFTQ | 276 | Q9Y473 | |
| CDSSLQSSMSGPGFC | 1341 | Q9Y493 |